GAITHERSBURG, Md.--Gene Logic said last week it would partner with a Rockville, Md., reagent company, Life Technologies, to fully sequence and file patents on 5 percent of the human genes that offer the “most promising gateways for new medicines against major diseases,” which have been identified using Gene Logic’s GeneExpress 200 database suite.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
